Article Details

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of ...

Retrieved on: 2024-01-31 21:36:08

Tags for this article:

Click the tags to see associated articles and topics

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of .... View article details on hiswai:

Summary

The provided article discusses Daré Bioscience's progress in market research for developing a treatment for female sexual arousal disorder (FSAD) with their Sildenafil Cream, which is advancing to a Phase 3 clinical study after the FDA meeting.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up